Nanobiosym Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Corporate
  • Investors
  • 8

Nanobiosym General Information

Description

Developer of a nanotechnology platform designed to create scientific insights and transformational technologies. The company's platform emerges from the holistic integration of physics and biomedicine to rapidly and accurately detect genetic fingerprints from any biological organism, enabling people to have affordable and portable diagnostic information about their own health.

Contact Information

Formerly Known As
Nanobiosym Research Institute
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Biotechnology
Primary Office
  • 245 First Street
  • 18th Floor
  • Cambridge, MA 02142
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanobiosym Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Corporate 18-Mar-2019 Completed Generating Revenue
5. Later Stage VC 25-Apr-2017 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Grant 07-Jul-2015 00000 Completed Generating Revenue
2. Angel (individual) 26-Feb-2015 Completed Generating Revenue
1. Grant 12-Dec-2013 $1.25M Completed Generating Revenue
To view Nanobiosym’s complete valuation and funding history, request access »

Nanobiosym Executive Team (6)

Name Title Board Seat Contact Info
Anita Goel Ph.D Founder, Chairman, President, Chief Executive Officer and Scientific Director
Homi Mullan Advisory Board Member
Ratan Tata Advisory Board Member
Robert Langer Ph.D Advisory Board Member
Tarun Khanna Ph.D Advisory Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

Nanobiosym Board Members (2)

Name Representing Role Since
Anita Goel Ph.D Nanobiosym Founder, Chairman, President, Chief Executive Officer and Scientific Director 000 0000
Paul Maritz Self Advisory Board Member 000 0000
To view Nanobiosym’s complete board members history, request access »

Nanobiosym Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanobiosym Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Unreasonable Group Holding Company Minority 000 0000 000000 0
Strathspey Crown Growth/Expansion Minority 000 0000 000000 0
Massachusetts Life Sciences Center Government 000 0000 000000 0
Paul Maritz Angel (individual) Minority 000 0000 000000 0
Air Force Office of Scientific Research Government 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »